跳至主要内容
临床试验/NCT03477513
NCT03477513已完成不适用

Personalized Treatment of Glioblastoma Via Image-Guided Predictive Modeling of Recurrence: A Single-Arm, Single Institutional Pilot Prospective Study of Dose-Escalated Radiation Therapy

Abramson Cancer Center at Penn Medicine2 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2018年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
23
试验地点
2
主要终点
Adverse Events

研究概览

简要总结

The study is a pilot study to estimate the efficacy of personalized dose-escalation radiation therapy in patients with glioblastoma, as measured by estimating the median of progression-free survival. Toxicity, patterns of recurrence, and overall median survival will be measured as secondary endpoints. Adverse events will be monitored.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with biopsy-proven WHO Grade IV glioblastoma, after gross-total or near-total resection, who are undergoing definitive chemoradiation as part of their treatment regimen
  • Age 18 or older
  • Ability to give signed informed consent
  • Karnofsky Performance Status (KPS) at least 70

排除标准

  • Placement of Gliadel wafers
  • Participation in another investigational trial
  • Active treatment of another malignancy

研究组 & 干预措施

Single Arm

Experimental

Dose-escalated radiation therapy

干预措施: Radation Therapy (Radiation)

结局指标

主要结局

Adverse Events

时间窗: 2 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验